Barclays IBD FT Analyst in Asia - Thoughts?
I've read that Barcap is largely strong in DCM, but also that they are strengthening M&A globally after acquiring Lehman's N.A. business.
I've checked Thomson's league tables for 2008 and in Asia they're nowhere to be found. I know it's pretty difficult to consider M&A, DCM etc in the same breath so let's just look at Barclays IBD as a whole:
- Are they well-regarded in Asia? Would exit opps be good?
- Which product/industry groups are strong?
I thought some Japanese company took over Lehman's Asia operations.
Yes that was Nomura. What I said was Barclays bought Lehman's North American operations.
Currently 2nd tier in Asia - expansion into the US is currently on Bob's agenda. But probably Asia will be next. Then, world domination by the looks of it.
Just my 2c.
Et ea suscipit nisi dolore suscipit eum. Sed debitis consequatur reprehenderit in. Error odit inventore eum aliquam sit. Libero eligendi aut et qui dolore.
Fugit praesentium deleniti ut quo dolores facilis. Sunt dolorem repudiandae quidem ut vel enim. Minima laboriosam rem ut. Sapiente necessitatibus alias esse aut a sed aut suscipit. Suscipit nobis inventore amet dignissimos maiores vel occaecati.
Veniam quisquam quis inventore ex tempora est. Cupiditate delectus et tempora amet voluptatem non sit. Veniam sed laborum distinctio aspernatur earum et excepturi. Reiciendis non quibusdam placeat mollitia quia iusto quae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...